Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.1M Buy
28,200
+10,200
+57% +$16.2M 0.04% 334
2026
Q1
$23.8M Buy
18,000
+12,000
+200% +$16.4M 0.02% 637
2025
Q4
$6.42M Buy
6,000
+4,700
+362% +$4.9M 0.01% 1040
2025
Q3
$1.26M Buy
+1,300
New +$1.02M ﹤0.01% 1841
2025
Q2
Sell
-5,300
Closed -$3.51M 2686
2025
Q1
$3.51M Sell
5,300
-75,700
-93% -$55.1M ﹤0.01% 1214
2024
Q4
$56.1M Buy
81,000
+61,200
+309% +$43.9M 0.07% 262
2024
Q3
$16.5M Buy
19,800
+18,300
+1,220% +$16.4M 0.02% 578
2024
Q2
$1.53M Buy
1,500
+1,400
+1,400% +$1.35M ﹤0.01% 1489
2024
Q1
$91.5K Buy
+100
New +$88.7K ﹤0.01% 2316

Other funds holding ASML

Marshall Wace's ASML Position: Q2 2026 in Review

Marshall Wace reduced its ASML (ASML) stake by 41% in Q2 2026, selling an estimated $144M and leaving 130,266 shares worth $259M. The position accounts for 0.2% of the portfolio, ranked #70.

Marshall Wace first reported a position in ASML in Q4 2015 and has held it in 19 quarters since. The position peaked at $291M in Q1 2026. 2,504 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Marshall Wace held 130,266 shares of ASML worth $259M as of Q2 2026.
  • Marshall Wace sold 90,307 ASML shares in Q2 2026, an estimated $144M.
  • ASML made up 0.2% of Marshall Wace's portfolio in Q2 2026, its #70 holding.
  • Marshall Wace first reported a position in ASML in Q4 2015 and has held it in 19 quarters since.
  • Marshall Wace's ASML position peaked at $291M in Q1 2026.
  • 2,504 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.